Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Dec 26 (Reuters) - Eli Lilly and Co LLY.N :
* POINT BIOPHARMA GLOBAL INC: ON DECEMBER 22, LILLY OFFER
EXPIRED
AND WAS NOT FURTHER EXTENDED - SEC FILING
* POINT BIOPHARMA GLOBAL INC: EXPECTS THAT ON DECEMBER 27,
LILLY
WILL COMPLETE ITS ACQUISITION OF POINT
Source text for Eikon: ID:
Further company coverage: LLY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower